Microbiome Diagnostics Market

Table of Content

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Microbiome Diagnostics
6.2.1. Key Role of Microbiome Diagnostics
6.2.2. Key Applications of the Microbiome Diagnostics Solutions
6.2.3. Challenges Associated with Microbiome Diagnostics

6.3. Future Perspective

7. REGULATORY SCENARIO

8. COMPREHENSIVE DATABASE OF LEADING PLAYERS

9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. Microbiome Diagnostics: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters

9.2.4. Microbiome Diagnostics Market: Overall Market Landscape
9.2.4.1. Analysis by Sample Type
9.2.4.2. Analysis by Product Type
9.2.4.3. Analysis by Technology Type
9.2.4.4. Analysis by Application Area
9.2.4.5. Analysis by End User

10. PORTER'S FIVE FORCES ANALYSIS

11. COMPETITIVE COMPETITIVENESS ANALYSIS

12. STARTUP ECOSYSTEM IN THE MICROBIOME DIAGNOSTICS MARKET
12.1. Microbiome Diagnostics: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure

12.2. Key Findings

13. COMPANY PROFILES
13.1. Chapter Overview
13.2. BD Biosciences (US)
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Diagnostics Products / Technologies
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook

* similar detail is presented for other below mentioned companies based on information in the public domain

13.3. BIOHM Health (US)
13.4. Bione Ventures (India)
13.5. Biome Diagnostics (Austria)
13.6. DayTwo (Israel)
13.7. DNA Genotek (US)
13.8. Enterome (US)
13.9. Evvy (New York)
13.10. Genetic Analysis (Norway)
13.11. Illumina (US)
13.12. Microba (US)
13.13. Oxford Nanopore Technologies (UK)
13.14. Quantbiome (Australia)
13.15. ViennaLab Diagnostics (Austria)
13.16. Viome Life Sciences (US)

14. PARTNERSHIPS AND COLLABORATIONS
14.1. Chapter Overview
14.2. Partnership Models

14.3. Microbiome Diagnostics: Partnerships and Collaborations
14.3.1. Analysis by Year of Partnership
14.3.2. Analysis by Type of Partnership
14.3.3. Analysis by Year and Type of Partnership
14.3.4. Analysis by Type of Partner
14.3.5. Analysis by Location of Headquarters of Partner
14.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner
14.3.7. Most Active Players: Analysis by Number of Partnerships
14.3.8. Regional Analysis

15. GLOBAL MICROBIOME DIAGNOSTICS MARKET
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Trends Disruption Impacting Market
15.4. Demand Side Trends
15.5. Supply Side Trends
15.6. Global Microbiome Diagnostics Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

15.7. Multivariate Scenario Analysis
15.7.1. Conservative Scenario
15.7.2. Optimistic Scenario

15.8. Investment Feasibility Index
15.9. Key Market Segmentations

16. MARKET OPPORTUNITIES BASED ON TYPE OF SAMPLE
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Microbiome Diagnostics Market for Skin: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Microbiome Diagnostics Market for Fecal: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. Microbiome Diagnostics Market for Saliva: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.9. Microbiome Diagnostics Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

16.10. Data Triangulation and Validation
16.10.1. Secondary Sources
16.10.2. Primary Sources
16.10.3. Statistical Modeling

17. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Microbiome Diagnostics Market for Instruments: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Microbiome Diagnostics Market for Reagents & Kits: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

17.8. Data Triangulation and Validation
17.8.1. Secondary Sources
17.8.2. Primary Sources
17.8.3. Statistical Modeling

18. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Microbiome Diagnostics Market for Metatranscriptomics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Microbiome Diagnostics Market for Shot Gun Metagenomics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Microbiome Diagnostics Market for 16S rRNA Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

18.9. Data Triangulation and Validation
18.9.1. Secondary Sources
18.9.2. Primary Sources
18.9.3. Statistical Modeling

19. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Microbiome Diagnostics Market for Research Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19.7. Microbiome Diagnostics Market for Disease Diagnostics Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7.1. Microbiome Diagnostics Market for Metabolic Diseases: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7.2. Microbiome Diagnostics Market for Gastrointestinal Disorders: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.7.3. Microbiome Diagnostics Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19.8. Data Triangulation and Validation
19.8.1. Secondary Sources
19.8.2. Primary Sources
19.8.3. Statistical Modeling

20. MARKET OPPORTUNITIES BASED ON END USER
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Microbiome Diagnostics Market for Academic & Research Institutes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.7. Microbiome Diagnostics Market for Hospitals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.8. Microbiome Diagnostics Market for Pharmaceutical & Biotechnology Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.9. Microbiome Diagnostics Market for Other End Users: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.10. Data Triangulation and Validation
20.10.1. Secondary Sources
20.10.2. Primary Sources
20.10.3. Statistical Modeling

21. MARKET OPPORTUNITIES FOR MICROBIOME DIAGNOSTICS IN NORTH AMERICA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Microbiome Diagnostics Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.1. Microbiome Diagnostics Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.2. Microbiome Diagnostics Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.3. Microbiome Diagnostics Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR MICROBIOME DIAGNOSTICS IN EUROPE
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Microbiome Diagnostics Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. Microbiome Diagnostics Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.2. Microbiome Diagnostics Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.3. Microbiome Diagnostics Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.4. Microbiome Diagnostics Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.5. Microbiome Diagnostics Market in The UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.6. Microbiome Diagnostics Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR MICROBIOME DIAGNOSTICS IN ASIA-PACIFIC
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix

23.6. Microbiome Diagnostics Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. Microbiome Diagnostics Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. Microbiome Diagnostics Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. Microbiome Diagnostics Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.4. Microbiome Diagnostics Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.5. Microbiome Diagnostics Market in New Zealand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.6. Microbiome Diagnostics Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.7. Data Triangulation and Validation

24. MARKET OPPORTUNITIES FOR MICROBIOME DIAGNOSTICS IN MIDDLE EAST & AFRICA (MEA)
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix

24.6. Microbiome Diagnostics Market in Middle East and Africa (MEA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.1. Microbiome Diagnostics Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.2. Microbiome Diagnostics Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.3. Microbiome Diagnostics Market in Iraq: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.4. Microbiome Diagnostics Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.5. Microbiome Diagnostics Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.6. Microbiome Diagnostics Market in South Africa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.7. Microbiome Diagnostics Market in United Araba Emirates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

24.7. Data Triangulation and Validation

25. MARKET OPPORTUNITIES FOR MICROBIOME DIAGNOSTICS IN LATIN AMERICA
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix

25.6. Microbiome Diagnostics Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.1. Microbiome Diagnostics Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
25.6.2. Microbiome Diagnostics Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

25.7. Data Triangulation and Validation

26. ADJACENT MARKET ANALYSIS

27. KEY WINNING STRATEGIES

28. VALUE CHAIN ANALYSIS

29. ROOTS STRATEGIC RECOMMENDATIONS

30. INSIGHTS FROM PRIMARY RESEARCH

31. REPORT CONCLUSION

32. TABULATED DATA

33. LIST OF COMPANIES AND ORGANIZATIONS

34. CUSTOMIZATION OPPORTUNITIES

35. ROOTS SUBSCRIPTION SERVICES

36. AUTHOR DETAILS